Immucell (ICCC) Receivables - Other (2009 - 2026)
Immucell (ICCC) reported Receivables - Other of $47,614 for Q3 2026, down 12.4% from $54,341 a year earlier but up 649.4% from the prior quarter.
Analysis
Immucell (ICCC) Receivables - Other (2009 - 2026) Analysis & Trends
At the end of FY2025, Immucell posted Receivables - Other of $31,177, down 23.1% from FY2024.
- Receivables - Other has declined for five consecutive years, with a five-year compound annual growth rate of -14.3% (FY2020 to FY2025).
- By year, Receivables - Other came in at $40,555 in FY2024 (-4.6%), $42,507 in FY2023 (-8.4%), $46,426 in FY2022 (-16.3%) and $55,490 in FY2021 (-17.9%).
- Five-year quarterly Receivables - Other spans a low of $6,354 in Q2 2026 and a high of $250,000 in Q3 2023.
- Year over year, Receivables - Other has now declined in each of the last four quarters, with growth averaging 0.3% over the last eight quarters.
- The high point for year-over-year Receivables - Other in five years was Q3 2023 (growth of 651.1%); the low point was Q3 2024 (a decline of 86.7%).
- Per Business Quant data, the three quarters before Q3 2026 came in at $6,354 (Q2 2026), $33,727 (Q1 2026) and $31,177 (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,276.89 Bn | 1,250.50 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 681.31 Bn | 601.18 Bn | 17.30 Bn |
| 3 | AbbVie | 520.63 Bn | 488.64 Bn | 13.12 Bn |
| 4 | Merck | 357.22 Bn | 320.16 Bn | 13.19 Bn |
| 5 | Novartis Ag | 310.90 Bn | 284.14 Bn | - |
| 6 | Astrazeneca | 285.12 Bn | 258.77 Bn | 13.26 Bn |
| 7 | Amgen | 250.23 Bn | 201.89 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 207.56 Bn | 182.67 Bn | 6.73 Bn |
| 9 | Pfizer | 164.42 Bn | 111.77 Bn | 12.56 Bn |
| 10 | Immucell | 102.43 Mn | 75.03 Mn | 3.56 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 47,614.00 |
| Jun 30, 2026 | 6,354.00 |
| Mar 31, 2026 | 33,727.00 |
| Dec 31, 2025 | 31,177.00 |
| Sep 30, 2025 | 54,341.00 |
| Jun 30, 2025 | 44,913.00 |
| Mar 31, 2025 | 56,381.00 |
| Dec 31, 2024 | 40,555.00 |
| Sep 30, 2024 | 33,342.00 |
| Jun 30, 2024 | 23,390.00 |
| Mar 31, 2024 | 52,630.00 |
| Dec 31, 2023 | 39,733.00 |
| Sep 30, 2023 | 250,000.00 |
| Jun 30, 2023 | 23,143.00 |
| Mar 31, 2023 | 51,793.00 |
| Dec 31, 2022 | 42,178.00 |
| Sep 30, 2022 | 33,286.00 |
| Jun 30, 2022 | 24,088.00 |
| Mar 31, 2022 | 53,150.00 |
| Dec 31, 2021 | 55,490.00 |
API Access
Immucell Receivables - Other API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables-other&ticker=ICCC&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables-other", "ticker": "ICCC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=receivables-other&ticker=ICCC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();